Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DeFi Development Corp.JNVR · Entity 6498 | Chief Financial Officer | April 09, 2025 | April 12, 2025 |
| PETMED EXPRESS INCPETS · Entity 7326 | Chief Financial Officer | July 30, 2021 | August 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DeFi Development Corp.
Report date April 09, 2025 · Filed April 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.38 · Expires 2035-04-09 | Direct | 5,000 |
Reported balance
After 2025-04-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-04-09 · Grant · Acquired 5,000 · Balance 5,000 F1: 12/48th of this option grant shall vest on the first year anniversary of the grant and thereafter, and thereafter one thirty sixth (1/36th) of the remainder number will vest each month for the next thirty-six months. |
| Common StockSEC Table I · non-derivative | Direct | 29,313 |
Reported balance
Holding disclosure · report date 2025-04-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 29,313 |
Filing footnotes · ownership attribution and instrument terms
F1: 12/48th of this option grant shall vest on the first year anniversary of the grant and thereafter, and thereafter one thirty sixth (1/36th) of the remainder number will vest each month for the next thirty-six months.
PETMED EXPRESS INC
Report date July 30, 2021 · Filed August 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,450 |
Reported balance
After 2021-07-30 transaction · row 1
1 source rowRow 1 · 2021-07-30 · Grant · Acquired 14,925 · Balance 45,450 F1: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2025 Filed Apr 12, 2025 01:09 UTC | DeFi Development Corp. JNVR · Entity 6498 | GrantOption (Right to buy) · Derivative | 5,000 | $0.00 Strike: $27.38 | $0.00 |
DisclosureSEC source: 0001213900-25-031246 · ownership.xml · derivative · entry 2 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2035-04-09 F1 · derivative.exercise_date: 12/48th of this option grant shall vest on the first year anniversary of the grant and thereafter, and thereafter one thirty sixth (1/36th) of the remainder number will vest each month for the next thirty-six months. Read SEC document |
| September 09, 2024 Filed Sep 11, 2024 16:24 UTC | DeFi Development Corp. JNVR · Entity 6498 | Exercise / conversionRestricted Stock Unit · Derivative | 56,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001575872-24-000994 · ownership.xml · derivative · entry 2 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Underlying: Common Stock · 56,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Janover Inc. common stock. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Janover Inc. common stock upon vesting of the RSU. F4 · derivative.exercise_date: One fourth (1/4th) of the RSUs vested on the one (1) year anniversary with one thirty sixth (1/36th) of the remainder number of RSUs scheduled to vest on each of the thirty-six (36), consecutive monthly vesting dates that occur after the first vesting date, which was September 7, 2023. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| September 09, 2024 Filed Sep 11, 2024 16:24 UTC | DeFi Development Corp. JNVR · Entity 6498 | Exercise / conversionCommon Stock | 56,250 | $0.46 | $25,875.00 |
DisclosureSEC source: 0001575872-24-000994 · ownership.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Janover Inc. common stock upon vesting of the RSU. F2 · price: The reported closing price of Janover Inc.'s common stock on 9/6/24 was $0.46 per share of common stock. Read SEC document |
| November 24, 2023 Filed Nov 27, 2023 22:24 UTC | DeFi Development Corp. JNVR · Entity 6498 | PurchaseCommon Stock | 500 | $0.91 | $455.00 |
DisclosureSEC source: 0001213900-23-090279 · ownership.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Read SEC document |
| September 15, 2023 Filed Sep 15, 2023 21:15 UTC | DeFi Development Corp. JNVR · Entity 6498 | PurchaseCommon Stock | 9,000 | $1.48 | $13,320.00 |
DisclosureSEC source: 0001213900-23-077082 · ownership.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $1.46 to $1.49, inclusive. The reporting person undertakes to provide Janover Inc., any security holder of Janover Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| July 30, 2021 Filed Aug 4, 2021 15:03 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 14,925 | $31.39 | $468,495.75 |
DisclosureSEC source: 0001437749-21-018456 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,450 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three-year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 15:56 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 6,000 | $42.50 | $255,000.00 |
DisclosureSEC source: 0001437749-21-014149 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,525 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan, which was executed on February 18, 2021, that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 28, 2021 Filed Jan 28, 2021 21:57 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCOMMON STOCK | 5,000 | $50.00 | $250,000.00 |
DisclosureSEC source: 0001437749-21-001506 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,525 Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 15:05 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 9,775 | $31.20 | $304,980.00 |
DisclosureSEC source: 0001437749-20-016428 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,525 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 17:24 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,334 | $40.00 | $133,360.00 |
DisclosureSEC source: 0001437749-20-008978 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,550 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 16:13 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,500 | $35.00 | $122,500.00 |
DisclosureSEC source: 0001437749-20-008662 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,884 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 18:12 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,500 | $32.50 | $113,750.00 |
DisclosureSEC source: 0001437749-20-007936 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,384 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 16:42 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,500 | $30.00 | $105,000.00 |
DisclosureSEC source: 0001437749-20-007253 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,884 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 17:20 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,500 | $28.22 | $98,770.00 |
DisclosureSEC source: 0001437749-20-003127 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,384 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:17 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 9,450 | $15.98 | $151,011.00 |
DisclosureSEC source: 0001437749-19-014915 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,884 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:17 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 10,500 | $35.43 | $372,015.00 |
DisclosureSEC source: 0001437749-18-014084 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,434 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| July 28, 2017 Filed Jul 31, 2017 14:45 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 10,500 | $48.37 | $507,885.00 |
DisclosureSEC source: 0001437749-17-013337 · rdgdoc.xml · nonDerivative · entry 2 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,934 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2017 Filed Jul 31, 2017 14:45 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 6,833 | $50.18 | $342,879.94 |
DisclosureSEC source: 0001437749-17-013337 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,534 Read SEC document |
| May 08, 2017 Filed May 9, 2017 19:53 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 9,000 | $27.00 | $243,000.00 |
DisclosureSEC source: 0001553350-17-000512 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:41 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 1,500 | $24.00 | $36,000.00 |
DisclosureSEC source: 0001553350-17-000479 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 20:49 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 1,500 | $23.00 | $34,500.00 |
DisclosureSEC source: 0001553350-16-002788 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 17:36 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 1,500 | $22.50 | $33,750.00 |
DisclosureSEC source: 0001553350-16-002768 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,267 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 19:25 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,000 | $21.75 | $65,250.00 |
DisclosureSEC source: 0001553350-16-002683 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 16:40 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 1,500 | $21.00 | $31,500.00 |
DisclosureSEC source: 0001553350-16-002521 · rosenbloom4.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,767 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.